新媒网 · 跨境数据社区

🔊Check out the Article Cutting-Edge Technology Without Cutting: Treating Skin Cancer in This Era—A Case Series" 📌Access the full paper here: https://shorturl.at/Hk7Yv 👏by Babar Rao MD, FAAD et al. Rutgers Robert Wood Johnson Medical School 🔸What are the main findings? Complete Tumor Clearance with SRT and RCM: All 38 lesions (24 SCC and 14 BCC) showed no residual tumor activity at the 6-month follow-up using reflectance confocal microscopy (RCM), achieving 100% tumor clearance. Dosage and Timing: Patients received an average radiation dose of 5522.2 cGy over seven weeks, with approximately three treatment sessions per week. Minimal Adverse Effects: Scarring and mild erythema were the primary adverse effects observed clinically, with six lesions showing moderate to severe inflammation on RCM at the 6-month follow-up. 🔸What are the implications of the main findings? (list three points) Improved Non-Invasive Monitoring: This study highlights the utility of Reflectance Confocal Microscopy (RCM) as a reliable, non-invasive tool for diagnosing and monitoring non-melanoma skin cancers (NMSCs). Support for Superficial Radiation Therapy (SRT): The findings validate the efficacy of SRT as a non-invasive treatment for NMSCs, achieving high tumor clearance rates and minimal scarring. SRT is especially beneficial for patients who are poor surgical candidates due to advanced age, comorbidities, or wound-healing concerns, providing a safer and less invasive alternative with improved quality of life. Complete non-invasive approach: The combination of SRT and RCM offers a unique ability to diagnose, treat and monitor NMSC entirely non-invasively without surgery. This has the potential to reduce traditional surgical complications and offer an alternative to poor surgical candidates.